Perinatal adversities in tuberous sclerosis complex: Determinants and neurodevelopmental outcomes

Alexa X D Zhang1, Holan Liang2,3, Fiona S McEwen2,4,5

  • 1Institute of Child Health, University College London, London, UK.

Insights

Perinatal adversity is higher in familial tuberous sclerosis complex (TSC), especially with maternal TSC. However, this adversity did not significantly impact neurodevelopmental outcomes in children with TSC.

Area of Science:

  • Genetics and Neurology
  • Developmental Pediatrics

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder with variable clinical manifestations.
  • Perinatal factors may influence neurodevelopmental outcomes in TSC, but their association requires further investigation.

Purpose of the Study:

  • To investigate the relationship between perinatal adversities and neurodevelopmental outcomes in children with TSC.
  • To compare perinatal adversity levels in children with TSC and their unaffected siblings.

Main Methods:

  • Prospective, longitudinal UK study (Tuberous Sclerosis 2000) involving 125 children with TSC.
  • Retrospective collection of perinatal histories using the Obstetric Enquiry Schedule and Gillberg Optimality Scale.
  • Neurodevelopmental outcomes assessed included intellectual ability, autism spectrum disorder, and attention-deficit/hyperactivity disorder.

Main Results:

  • Children with familial TSC experienced significantly greater perinatal adversity compared to unaffected siblings.
  • Maternal TSC was associated with higher levels of perinatal adversity, unlike paternal TSC.
  • No significant association was found between perinatal adversities and neurodevelopmental outcomes after controlling for confounders.

Conclusions:

  • Maternal TSC is a marker for increased perinatal risk.
  • Increased vigilance is recommended for pregnancies complicated by maternal or fetal TSC.
  • Further research is needed to understand the mechanisms behind increased perinatal adversity in TSC.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
42.9K